GB0806746D0 - Membrane - Google Patents

Membrane

Info

Publication number
GB0806746D0
GB0806746D0 GBGB0806746.4A GB0806746A GB0806746D0 GB 0806746 D0 GB0806746 D0 GB 0806746D0 GB 0806746 A GB0806746 A GB 0806746A GB 0806746 D0 GB0806746 D0 GB 0806746D0
Authority
GB
United Kingdom
Prior art keywords
membrane
cells
useful
treatment
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0806746.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB0806746.4A priority Critical patent/GB0806746D0/en
Publication of GB0806746D0 publication Critical patent/GB0806746D0/en
Priority to AU2009237462A priority patent/AU2009237462B2/en
Priority to JP2011504521A priority patent/JP5552478B2/ja
Priority to NZ587753A priority patent/NZ587753A/en
Priority to RU2010144399/10A priority patent/RU2530169C2/ru
Priority to EP09732279.6A priority patent/EP2265711B1/en
Priority to CA2720264A priority patent/CA2720264C/en
Priority to US12/933,694 priority patent/US8642072B2/en
Priority to DK09732279.6T priority patent/DK2265711T3/en
Priority to CN200980113395.3A priority patent/CN102016009B/zh
Priority to MYPI2010004529A priority patent/MY159049A/en
Priority to KR1020137014211A priority patent/KR20130065737A/ko
Priority to PCT/GB2009/000917 priority patent/WO2009127809A1/en
Priority to BRPI0910936A priority patent/BRPI0910936A2/pt
Priority to KR1020107022953A priority patent/KR101317094B1/ko
Priority to MX2010011232A priority patent/MX2010011232A/es
Priority to ES09732279.6T priority patent/ES2665284T3/es
Priority to ZA2010/06326A priority patent/ZA201006326B/en
Priority to IL208745A priority patent/IL208745A/en
Priority to CO10142317A priority patent/CO6311115A2/es
Priority to US14/146,744 priority patent/US8889179B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0806746.4A 2008-04-14 2008-04-14 Membrane Ceased GB0806746D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB0806746.4A GB0806746D0 (en) 2008-04-14 2008-04-14 Membrane
ES09732279.6T ES2665284T3 (es) 2008-04-14 2009-04-08 Membrana
MYPI2010004529A MY159049A (en) 2008-04-14 2009-04-08 Membrane
PCT/GB2009/000917 WO2009127809A1 (en) 2008-04-14 2009-04-08 Membrane
NZ587753A NZ587753A (en) 2008-04-14 2009-04-08 Membrane with retina cells
RU2010144399/10A RU2530169C2 (ru) 2008-04-14 2009-04-08 Мембрана в качестве подложки для выращивания клеток ретинального пигментного эпителия (варианты), ее применение и способ засевания таких клеток
EP09732279.6A EP2265711B1 (en) 2008-04-14 2009-04-08 Membrane
CA2720264A CA2720264C (en) 2008-04-14 2009-04-08 A membrane for supporting the growth of retinal pigmented epithelial cells
US12/933,694 US8642072B2 (en) 2008-04-14 2009-04-08 Membrane
DK09732279.6T DK2265711T3 (en) 2008-04-14 2009-04-08 CONE
CN200980113395.3A CN102016009B (zh) 2008-04-14 2009-04-08 膜
AU2009237462A AU2009237462B2 (en) 2008-04-14 2009-04-08 Membrane
KR1020137014211A KR20130065737A (ko) 2008-04-14 2009-04-08 멤브레인
JP2011504521A JP5552478B2 (ja) 2008-04-14 2009-04-08 膜
BRPI0910936A BRPI0910936A2 (pt) 2008-04-14 2009-04-08 membrana
KR1020107022953A KR101317094B1 (ko) 2008-04-14 2009-04-08 멤브레인
MX2010011232A MX2010011232A (es) 2008-04-14 2009-04-08 Membrana.
ZA2010/06326A ZA201006326B (en) 2008-04-14 2010-09-03 Membrane
IL208745A IL208745A (en) 2008-04-14 2010-10-14 Membranes support cell growth and use
CO10142317A CO6311115A2 (es) 2008-04-14 2010-11-12 Membrana porosa no-biodegradable para soporte de crecimiento de células
US14/146,744 US8889179B2 (en) 2008-04-14 2014-01-03 Membrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0806746.4A GB0806746D0 (en) 2008-04-14 2008-04-14 Membrane

Publications (1)

Publication Number Publication Date
GB0806746D0 true GB0806746D0 (en) 2008-05-14

Family

ID=39433610

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0806746.4A Ceased GB0806746D0 (en) 2008-04-14 2008-04-14 Membrane

Country Status (19)

Country Link
US (2) US8642072B2 (https=)
EP (1) EP2265711B1 (https=)
JP (1) JP5552478B2 (https=)
KR (2) KR101317094B1 (https=)
CN (1) CN102016009B (https=)
AU (1) AU2009237462B2 (https=)
BR (1) BRPI0910936A2 (https=)
CA (1) CA2720264C (https=)
CO (1) CO6311115A2 (https=)
DK (1) DK2265711T3 (https=)
ES (1) ES2665284T3 (https=)
GB (1) GB0806746D0 (https=)
IL (1) IL208745A (https=)
MX (1) MX2010011232A (https=)
MY (1) MY159049A (https=)
NZ (1) NZ587753A (https=)
RU (1) RU2530169C2 (https=)
WO (1) WO2009127809A1 (https=)
ZA (1) ZA201006326B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110112101A1 (en) * 2009-03-05 2011-05-12 Sanofi-Aventis Treatment for ocular-related disorders
ES2750028T3 (es) * 2010-05-10 2020-03-24 Tsutomu Yasukawa Método de producción de una lámina celular
AU2011279250B2 (en) 2010-07-12 2014-12-04 California Institute Of Technology Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
CN103459593A (zh) * 2011-02-25 2013-12-18 独立行政法人理化学研究所 视网膜色素上皮细胞片层的生产方法
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
WO2012177968A1 (en) * 2011-06-22 2012-12-27 The Schepens Eye Research Institute, Inc. A scaffold for subretinal cell transplantation and drug delivery
KR101970846B1 (ko) * 2011-07-11 2019-08-13 이어 사이언스 인스티튜트 오스트레일리아 이어 드럼 복원용 장치
CN103007355B (zh) * 2011-09-20 2014-08-13 同济大学 一种水凝胶-纳米纤维膜及其制备方法和用途
CA2792081C (en) * 2011-10-11 2020-10-27 Bond University Ltd Layered compositions comprising 3d nanofibre webbing for tissue repair
TWI719277B (zh) 2011-11-14 2021-02-21 美商安斯泰來再生醫藥協會 人類rpe細胞之醫藥組合物及其用途
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
US20130330825A1 (en) * 2012-06-07 2013-12-12 City Of Hope Attachment substrates for directed differentiation of human embryonic stem cells in culture
BR112015003839B1 (pt) 2012-08-24 2021-12-28 Riken Método para produzir lâmina de células do epitélio pigmentar da retina
RU2518972C1 (ru) * 2012-12-24 2014-06-10 Общество с ограниченной ответственностью "НАНО КАСКАД" Трековая мембрана для фильтрации крови
CA2933083A1 (en) 2013-12-11 2015-06-18 Pfizer Limited Method for producing retinal pigment epithelial cells
CN105013010B (zh) * 2015-07-07 2018-01-12 中山大学中山眼科中心 一种辅助iPS‑RPE移植的层粘连蛋白膜
CN105597145A (zh) * 2016-02-22 2016-05-25 中山大学中山眼科中心 一种视网膜细胞支架生物手术粘合剂及其制备方法
WO2018003858A1 (ja) * 2016-06-28 2018-01-04 国立研究開発法人農業・食品産業技術総合研究機構 細胞封入用デバイス及びその使用
EP3843798A1 (en) 2018-08-31 2021-07-07 Wisconsin Alumni Research Foundation Generating arterial endothelial cell-seeded vascular grafts
AU2020260894B2 (en) * 2019-04-26 2025-06-05 Racthera Co., Ltd. Composite including neural retina, retinal pigment epithelial cells, and hydrogel, and method for producing same
RU2704094C1 (ru) * 2019-05-16 2019-10-23 федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ трансплантации ретинального пигментного эпителия в форме многоклеточных 3D сфероидов в эксперименте
JP2021141877A (ja) * 2020-03-13 2021-09-24 大日本印刷株式会社 細胞培養基材、細胞付細胞培養基材、細胞培養容器、細胞付細胞培養容器、上皮細胞シート及びその製造方法、被験物質の評価方法並びに評価キット
JP7676135B2 (ja) * 2020-12-14 2025-05-14 日本バイリーン株式会社 細胞培養担体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118984D0 (en) * 2001-08-03 2001-09-26 Intercytex Ltd Fusion of cells
CN1739813A (zh) * 2005-09-15 2006-03-01 上海赐人合元企业发展有限公司 组织工程表皮替代物及其制备方法
KR100901343B1 (ko) 2007-07-23 2009-06-05 (주)실리콘화일 결정질 반도체 박막 제조 방법
RU2368359C1 (ru) * 2008-07-22 2009-09-27 Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) Способ лечения возрастной макулярной дегенерации

Also Published As

Publication number Publication date
MY159049A (en) 2016-12-15
AU2009237462B2 (en) 2012-12-20
IL208745A (en) 2015-04-30
MX2010011232A (es) 2011-02-23
KR20100128329A (ko) 2010-12-07
WO2009127809A1 (en) 2009-10-22
RU2530169C2 (ru) 2014-10-10
BRPI0910936A2 (pt) 2015-10-06
RU2010144399A (ru) 2012-05-20
US8642072B2 (en) 2014-02-04
JP2011517696A (ja) 2011-06-16
ES2665284T3 (es) 2018-04-25
KR20130065737A (ko) 2013-06-19
EP2265711A1 (en) 2010-12-29
KR101317094B1 (ko) 2013-10-16
CN102016009A (zh) 2011-04-13
US8889179B2 (en) 2014-11-18
DK2265711T3 (en) 2018-04-30
ZA201006326B (en) 2011-09-28
AU2009237462A1 (en) 2009-10-22
CA2720264A1 (en) 2009-10-22
EP2265711B1 (en) 2018-03-07
CN102016009B (zh) 2015-05-20
JP5552478B2 (ja) 2014-07-16
IL208745A0 (en) 2010-12-30
US20110236464A1 (en) 2011-09-29
US20140127282A1 (en) 2014-05-08
NZ587753A (en) 2012-07-27
CO6311115A2 (es) 2011-08-22
CA2720264C (en) 2016-09-27

Similar Documents

Publication Publication Date Title
GB0806746D0 (en) Membrane
MX2011011402A (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
MY158160A (en) Improved isoprene production using the dxp and mva pathway
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
EP4585589A3 (en) Stem cell cultures
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
PH12012500818A1 (en) Pluripotent stem cells
EA201070605A1 (ru) Применение бактерий для производства биоэнергии
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
WO2010078952A3 (de) Strukturierte gasdiffusionselektrode für elektrolysezellen
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
MY182946A (en) Production of organic acids by fermentation at low ph
TN2011000355A1 (en) Novel microbiocides
MY159244A (en) Method of reducing intraocular pressure in humans
EA201101626A1 (ru) Бактерии с высокоэффективным метаболизмом
EA201171141A1 (ru) Твердый ретигабин в некристаллической форме
MY160945A (en) Use of accommodative error measurements in providing ophthalmic lenses
MX336392B (es) Derivados de hidroximoil-heterociclos fungicidas.
MX2011013790A (es) Derivados de flavina.
TN2011000531A1 (en) 5- alkynyl - pyridines
WO2012016172A3 (en) Genetically modified microbes producing increased levels of acetyl-coa derived compounds
IN2012DN01223A (https=)
MX2012007283A (es) Composiciones para vacunas.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)